Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04121793 · ClinicalTrials.gov registry record
Objective Quality of Life Detection Validation
A clinical trial, sponsored by Great Lakes NeuroTechnologies.
- Completed
- Registry status
- 10
- Enrollment target
NCT04121793 is a clinical trial that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 10 participants.
The verdict
NCT04121793 has completed, sponsored by Great Lakes NeuroTechnologies.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this research study is to: * Collect data to use in the development of a standardized tool for identifying patients with Parkinson's disease (PD) who would benefit from advanced therapies (AT) such as deep brain stimulation (DBS) and drug pumps. * Determine the level to which specific activities reflect with quality of life in individuals with PD. * Obtain feedback from individuals with Parkinson's disease and clinicians on the usability of the system.
Interventions
- DEVICE Kinesia 360 and Smartphone sensors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-09-20 |
| Est. Completion | 2020-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04121793
The ClinicalTrials.gov registry entry for NCT04121793 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Great Lakes NeuroTechnologies, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Kinesia 360 and Smartphone sensors is the first listed.
NCT04121793 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04121793 about?
NCT04121793 is a clinical study titled "Objective Quality of Life Detection Validation". The purpose of this research study is to: * Collect data to use in the development of a standardized tool for identifying patients with Parkinson's disease (PD) who would benefit from advanced therapies (AT) such as deep brain stimulation (DBS) and drug pumps. * Determine the level to which specifi...
What is the current status of trial NCT04121793?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2019-09-20. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT04121793?
The interventions under investigation include: Kinesia 360 and Smartphone sensors (DEVICE).
Who is sponsoring clinical trial NCT04121793?
This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.